4.2 Article

Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs

Journal

HUMAN IMMUNOLOGY
Volume 77, Issue 11, Pages 1092-1100

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2016.04.003

Keywords

HLA-DQ; Donor-specific-antibodies; HLA-DP; Antibody-mediated rejection; Endothelial cell

Categories

Ask authors/readers for more resources

During solid organ transplantation, interactions between recipient and donor immune cells occur chiefly in the allograft microvasculature. All three HLA class II antigens, DR, DP and DQ, have been detected on renal EC with a markedly increased expression of HLA class II observed in renal allografts undergoing rejection. Recent studies of donor-specific antibodies (DSA) have exposed the prevalence of de novo DSA directed against HLA-DQ as well as a strong association between these antibodies and allograft damage. The HLA-DQ molecule can be distinguished from the other class II antigens by its transcription, expression and peptide repertoire. The distinct intragraft expression and immunogenicity of HLA-DQ may contribute to the incidence of HLA-DQ DSA, as well as directing the DSA-mediated damage. The possibility of HLA class II antigen-specific signaling in EC may reveal different mechanisms of allograft damage that act in tandem with complement-dependent injury. This review addresses the features of the HLA-DQ heterodimer that may underlie the high incidence of HLA-DQ directed DSA and their association with allograft damage. We also consider existing data in hematopoietic stem cell transplantation concerning HLA directed DSA. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

T cell antigenicity and immunogenicity of allogeneic exosomes

Aurore Prunevieille, Mohamed H. Babiker-Mohamed, Colleen Aslami, Bruno Gonzalez-Nolasco, Nuala Mooney, Gilles Benichou

Summary: Studies have shown that allogeneic exosomes can activate T cells in vivo and sensitize mice to alloantigens, but only when delivered in an inflammatory environment.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Biochemistry & Molecular Biology

Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection

Nicolas Degauque, Alain Haziot, Sophie Brouard, Nuala Mooney

Summary: In the inflammation and infection caused by SARS-CoV-2, endothelial cells play a crucial role in regulating the recruitment of immune cells and interacting with monocytes, T cells, and B cells. Endothelial cells function as an integrative and active platform for immune responses, providing opportunities for therapeutic intervention.

FASEB JOURNAL (2021)

Article Immunology

Inflammation Determines the Capacity of Allogenic Endothelial Cells to Regulate Human Treg Expansion

Amy Rachael Cross, Julien Lion, Karine Poussin, Denis Glotz, Nuala Mooney

Summary: This study investigates the impact of inflammation on endothelial regulation of CD4(+)Treg cells. The findings suggest that high levels of inflammation can impair endothelial cell function and lead to inhibition of Treg differentiation. Blocking PD-L1 can partially restore Treg cell numbers.

FRONTIERS IN IMMUNOLOGY (2021)

Review Hematology

Endothelial cells: major players in acute myeloid leukaemia

Sofiane Fodil, Marine Arnaud, Camille Vaganay, Alexandre Puissant, Etienne Lengline, Nuala Mooney, Raphael Itzykson, Lara Zafrani

Summary: The vascular microenvironment plays a crucial role in AML, with ECs and leukemic cells interacting to influence disease progression and complications.

BLOOD REVIEWS (2022)

Review Biochemistry & Molecular Biology

Cytokines in Liver Transplantation

Sara Assadiasl, Nuala Mooney, Mohammad Hossein Nicknam

Summary: Cytokines play crucial roles in autoimmune, allergic, and infectious diseases, as well as allograft rejection. Recent advances in novel anti-cytokine agents and gene therapy for immunomodulatory cytokines have shown significant improvements in managing dysregulated cytokine secretion and overexpression.

CYTOKINE (2021)

Article Cell Biology

Hematopoietic progenitors polarize in contact with bone marrow stromal cells in response to SDF1

Thomas Bessy, Adrian Candelas, Benoit Souquet, Khansa Saadallah, Alexandre Schaeffer, Benoit Vianay, Damien Cuvelier, Samy Gobaa, Cecilia Nakid-Cordero, Julien Lion, Jean-Christophe Bories, Nuala Mooney, Thierry Jaffredo, Jerome Larghero, Laurent Blanchoin, Lionel Faivre, Stephane Brunet, Manuel Thery

Summary: The study reveals that the interaction between HSPCs and bone marrow stromal cells can induce polarization of HSPCs, leading to changes in cytoskeleton architecture, specifically the centrosome positioning. This polarization is specific and involves receptors ICAM, VCAM, and SDF1, with SDF1 being capable of independently inducing centrosome-microtubule network polarization.

JOURNAL OF CELL BIOLOGY (2021)

Article Urology & Nephrology

Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms

Marine Arnaud, Maud Loiselle, Camille Vaganay, Stphanie Pons, Emmanuel Letavernier, Jordane Demonchy, Sofiane Fodil, Manal Nouacer, Sandrine Placier, Perrine Frere, Eden Arrii, Julien Lion, Nuala Mooney, Raphael Itzykson, Chakib Djediat, Alexandre Puissant, Lara Zafrani

Summary: This study provides new insights into the pathophysiology of TLS-induced AKI and suggests that extracellular histones may be a novel target for therapeutic intervention in TLS when endothelial dysfunction occurs.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Editorial Material Medicine, General & Internal

Urinary metabolites give new clues to kidney transplant tolerance

Nuala Mooney

EBIOMEDICINE (2022)

Article Immunology

Relevance of Anti-HLA Antibody Strength Underestimation in Single Antigen Bead Assay for Shared Eplets

Guillaume Claisse, Magali Devriese, Julien Lion, Nicolas Maillard, Sophie Caillat-Zucman, Nuala Mooney, Jean Luc Taupin

Summary: This study experimentally validated that the assumption of underestimating the signal of anti-HLA antibodies in single antigen bead (SAB) assays when multiple beads share the targeted eplet is not true. Therefore, this phenomenon should no longer be considered as a significant risk factor during patient follow-up pre- or post-transplantation.

TRANSPLANTATION (2022)

Article Surgery

Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment

Julien Lion, Mathilde Le Maitre, Camille de Truchis, Jean-Luc Taupin, Karine Poussin, Alain Haziot, Edward Chong, Denis Glotz, Nuala Mooney

Summary: The microvascular endothelium of the renal transplant is the first site of graft interaction with the host immune system and is often injured in chronic Antibody Mediated Rejection (AMR). IL-6 plays a crucial role in EC immunogenicity, and blocking IL-6 can help improve related inflammatory responses.

CLINICAL TRANSPLANTATION (2022)

Article Gastroenterology & Hepatology

Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans

Tiong Y. Lim, Elena Perpinan, Maria-Carlota Londono, Rosa Miquel, Paula Ruiz, Ada S. Kurt, Elisavet Kodela, Amy R. Cross, Claudia Berlin, Joanna Hester, Fadi Issa, Abdel Douiri, Felix H. Volmer, Richard Taubert, Evangelia Williams, Anthony J. Demetris, Andrew Lesniak, Gilbert Bensimon, Juan Jose Lozano, Marc Martinez-Llordella, Tim Tree, Alberto Sanchez-Fueyo

Summary: This study investigated the role of low-dose IL-2 (LDIL-2) in maintaining liver allograft tolerance. The results showed that LDIL-2 expanded circulating regulatory T cells (Tregs) but failed to effectively suppress antigen-specific immune responses and promote the accumulation of intrahepatic Tregs. Furthermore, LDIL-2 induced a liver transcriptional response even before immunosuppression weaning. The study was terminated after the first 6 participants failed to reach the primary endpoint, requiring reinstitution of immunosuppression.

JOURNAL OF HEPATOLOGY (2023)

Article Immunology

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology

Fabrice Cognasse, Hind Hamzeh-Cognasse, Anne-Claire Duchez, Natalia Shurko, Marie-Ange Eyraud, Charles-Antoine Arthaud, Amelie Prier, Marco Heestermans, Olivier Hequet, Brigitte Bonneaudeau, Sandrine Rochette-Eribon, Francoise Teyssier, Valerie Barlet-Excoffier, Patricia Chavarin, Dominique Legrand, Pascale Richard, Pascal Morel, Nuala Mooney, Pierre Tiberghien

Summary: Blood products in therapeutic transfusion contain biologically active constituents. This study investigated the effect of photochemical Pathogen Reduction Treatment (PRT) on inflammatory factors and endothelial cells in convalescent plasma. The results showed that most inflammatory soluble factors did not significantly change before and after PRT, but IL-8 concentrations decreased significantly and IL-18 concentrations increased. In addition, the release of IL-6 from cFFP was similar regardless of PRT treatment. Further research is needed to explore the physiological effects of IL-18 and IL-8, as well as the clinical relevance of PRT-treated convalescent plasma.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Plasma iron controls neutrophil production and function

Joe N. Frost, Sarah K. Wideman, Alexandra E. Preston, Megan R. Teh, Zhichao Ai, Lihui Wang, Amy Cross, Natasha White, Yavuz Yazicioglu, Michael Bonadonna, Alexander J. Clarke, Andrew E. Armitage, Bruno Galy, Irina A. Udalova, Hal Drakesmith

Summary: Low plasma iron induced by hepcidin inhibits neutrophil production and alters their effector functions, while having no significant effect on other types of white blood cells. Antagonizing endogenous hepcidin can enhance neutrophil production during acute inflammation. These findings suggest that plasma iron plays a role in modulating the profile of innate immunity, with potential therapeutic implications.

SCIENCE ADVANCES (2022)

Article Surgery

Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment

Julien Lion, Mathilde Le Maitre, Camille de Truchis, Jean-Luc Taupin, Karine Poussin, Alain Haziot, Edward Chong, Denis Glotz, Nuala Mooney

Summary: The microvascular endothelium of the renal transplant is the first site of graft interaction with the host immune system and is often injured in chronic Antibody Mediated Rejection (AMR). IL-6 blockade is currently under investigation as a therapeutic target for AMR. This study examined the role of IL-6 in endothelial cell immunogenicity and found that IL-6 blockade reduced pro-inflammatory responses in EC.

CLINICAL TRANSPLANTATION (2023)

Article Medicine, Research & Experimental

Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury

Amy R. Cross, Carlos E. de Andrea, Maria Villalba-Esparza, Manuel F. Landecho, Lucia Cerundolo, Praveen Weeratunga, Rachel E. Etherington, Laura Denney, Graham Ogg, Ling -Pei Ho, Ian S. D. Roberts, Joanna Hester, Paul Klenerman, Ignacio Melero, Stephen N. Sansom, Fadi Issa

Summary: This study used spatial transcriptomics to explore the interactions between different immune and stromal cell populations in COVID-19-affected lung tissue. Through gene expression analysis of well-preserved lung samples from 3 patients, a common immune-cell signaling circuit involving cytotoxic lymphocytes and pro-inflammatory macrophages was identified in areas of severe lung damage. The expression of IFNG by cytotoxic lymphocytes was associated with the induction of chemokines, while TNF superfamily members (BAFF and TRAIL) were consistently upregulated in severely damaged areas. Validation of these findings in additional COVID-19 patient cohorts supports the potential use of this immune-mediated tissue pathology model for future therapeutic strategies.

JCI INSIGHT (2023)

No Data Available